cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.17182/hepdata.166415.v1/t2
title: "Figure 6" of "Projected sensitivity for non-resonant production of vector leptoquarks and single production of vector-like $T$ quarks in final states with b-jets with the ATLAS experiment at the HL-LHC"

description: 95% confidence level exclusion contour in the (<em>m<sub>VLQ</sub>, κ</em>) plane, for LHC Run 2 (140 fb<sup>−1</sup>), <em>3 ab<sup>−1</sup></em>, and <em>6 ab<sup>−1</sup></em>. Consistent with previous ATLAS studies, parameter points where the VLQ width is more than half the VLQ mass are excluded (the grey region), as, due to the breakdown of the narrow-width approximation, the theoretical calculations become unreliable. The Run 2 <em>T → Wb</em> contour comes from Ref. [26], and the Run 2 combination refers to Ref. [27].
description: Projected sensitivity for $t$-channel vector leptoquark in final states with $b$-jets, and single-production vector-like $T$ quark (VLT) decaying to $W(\ell \nu)b$, using the ATLAS experiment at the High Luminosity LHC (HL-LHC) is presented: obtained from the extrapolation of analyses from the Run 2 dataset, using 140 $\mathrm{fb^{-1}}$ of data at $\sqrt{s} = 13$ TeV. Two scenarios for the systematic uncertainties are taken into account. The baseline scenario assumes that the systematic uncertainties are reduced by taking into account the increased amount of data, while the Run 2 scenario assumes the same systematic uncertainties as used in the Run 2 analysis. For the leptoquark, the expected limit on $\beta$ using baseline (Run 2) scenario of systematic uncertainty improves about 30% (20%) and 40% (20%) for the case of 3 $\mathrm{ab^{-1}}$ and 6 $\mathrm{ab^{-1}}$, respectively. For the VLT at 3 $\mathrm{ab^{-1}}$, the limit on $\kappa$ at a given mass improves significantly, being reduced by about 30% at 1.2 TeV up to about 60% at 2.3 TeV, with only modest additional gains achievable through further improvements in systematics or the use of the full 6 $\mathrm{ab^{-1}}$ dataset. The range of masses that can be studied within the constraints of the narrow-width approximation is extended from 2.3 TeV to over 2.7 TeV.
DOI: 10.5281/zenodo.18328980
title: THE IMPACT OF STUDYING ABROAD ON PERSONAL DEVELOPMENT

description: This article examines the importance of studying abroad in the context of higher education and its role in shaping students’ personal growth. It highlights how international academic experiences contribute to the development of psychological resilience, intercultural awareness, and global competence.
DOI: 10.5281/zenodo.18328979
title: THE IMPACT OF STUDYING ABROAD ON PERSONAL DEVELOPMENT

description: This article examines the importance of studying abroad in the context of higher education and its role in shaping students’ personal growth. It highlights how international academic experiences contribute to the development of psychological resilience, intercultural awareness, and global competence.
DOI: 10.18742/31043536
title: PSYD_3202: UOS

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: Longitudinal </b><b>Study of Individuals with</b><b> Schizophrenia Spectrum and Other Psychotic Disorders (schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, schizotypal personality disorder or psychosis not otherwise specified)</b><b>Contributors and PI’s:</b> Rafael Romero-GarcíaDepartment of Medical Physiology and Biophysics, University of Seville, Spain<br><b>Key Details & Variables</b><pre></pre><b>Age Range</b>17-62<b>Number of Participants</b>328<b>Diagnostic Criteria</b>SCZ, SAD, BPD, Others<b>Number of Clinical Subjects</b>201<b>Number of Clinical Subjects (follow-up)</b>178<b>Number of Control Subjects</b>115<b>Number of Control Subjects (follow-up)</b>134<b>Demographic Information</b>Age, Sex, Ethnicity, Education<b>Clinical Measures</b>SANS, SAPS, BPRS<b>Cognitive Measures</b>Global Cognitive Functioning Verbal Memory<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>N/A<b>Antipsychotic Dose Recorded</b>N/A<b>CPZ Equivalents Recorded</b>Yes<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>No<br>
DOI: 10.18742/31043536.v1
title: PSYD_3202: UOS

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: Longitudinal </b><b>Study of Individuals with</b><b> Schizophrenia Spectrum and Other Psychotic Disorders (schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, schizotypal personality disorder or psychosis not otherwise specified)</b><b>Contributors and PI’s:</b> Rafael Romero-GarcíaDepartment of Medical Physiology and Biophysics, University of Seville, Spain<br><b>Key Details & Variables</b><pre></pre><b>Age Range</b>17-62<b>Number of Participants</b>328<b>Diagnostic Criteria</b>SCZ, SAD, BPD, Others<b>Number of Clinical Subjects</b>201<b>Number of Clinical Subjects (follow-up)</b>178<b>Number of Control Subjects</b>115<b>Number of Control Subjects (follow-up)</b>134<b>Demographic Information</b>Age, Sex, Ethnicity, Education<b>Clinical Measures</b>SANS, SAPS, BPRS<b>Cognitive Measures</b>Global Cognitive Functioning Verbal Memory<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>N/A<b>Antipsychotic Dose Recorded</b>N/A<b>CPZ Equivalents Recorded</b>Yes<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>No<br>
DOI: 10.15468/dl.frm6kj
title: Occurrence Download

description: A dataset containing 29 species occurrences available in GBIF matching the query:
{"type":"and","predicates":[{"type":"within","geometry":"POLYGON ((-73.851 7.682108, -73.92189399999999 7.676536, -73.99103700000001 7.659959, -74.05672199999999 7.632785, -74.117328 7.595685, -74.171359 7.549576, -74.21748599999999 7.495595, -74.254572 7.435074, -74.28170799999999 7.369505, -74.29822900000001 7.300506, -74.30373299999999 7.229775, -74.29809 7.159055, -74.28144399999999 7.090087, -74.25420800000001 7.024567, -74.21705799999999 6.964108, -74.17090899999999 6.910195, -74.1169 6.864154, -74.056358 6.827116, -73.990773 6.79999, -73.921755 6.783444, -73.851 6.777883, -73.78024499999999 6.783444, -73.71122699999999 6.79999, -73.645642 6.827116, -73.5851 6.864154, -73.531091 6.910195, -73.484942 6.964108, -73.44779200000001 7.024567, -73.420556 7.090087, -73.40391 7.159055, -73.398267 7.229775, -73.40377100000001 7.300506, -73.420292 7.369505, -73.447428 7.435074, -73.484514 7.495595, -73.530641 7.549576, -73.584672 7.595685, -73.645278 7.632785, -73.71096300000001 7.659959, -73.780106 7.676536, -73.851 7.682108))"},{"type":"equals","key":"CLASS_KEY","value":"212","matchCase":false},{"type":"greaterThanOrEquals","key":"YEAR","value":"2015","matchCase":false},{"type":"not","predicate":{"type":"in","key":"BASIS_OF_RECORD","values":["MATERIAL_CITATION","MATERIAL_SAMPLE","PRESERVED_SPECIMEN"],"matchCase":false}},{"type":"lessThanOrEquals","key":"COORDINATE_UNCERTAINTY_IN_METERS","value":"10000","matchCase":false},{"type":"equals","key":"LICENSE","value":"CC BY 4.0","matchCase":false}]}

 The dataset includes 29 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002830-260120142942310/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.18742/31043515
title: PSYD_3201: UOS

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: Longitudinal </b><b>Study of Individuals with</b><b> Schizophrenia Spectrum and Other Psychotic Disorders (schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, schizotypal personality disorder or psychosis not otherwise specified)</b><b>Contributors and PI’s:</b> Rafael Romero-GarcíaDepartment of Medical Physiology and Biophysics, University of Seville, Spain<br><b>Key Details & Variables</b><pre></pre><b>Age Range</b>15-73<b>Number of Participants</b>224<b>Diagnostic Criteria</b>SCZ, SAD, BPD<b>Number of Clinical Subjects</b>206<b>Number of Clinical Subjects (follow-up)</b>192<b>Number of Control Subjects</b>78<b>Number of Control Subjects (follow-up)</b>189<b>Demographic Information</b>Age, Sex, Ethnicity, Education<b>Clinical Measures</b>SANS, SAPS, BPRS<b>Cognitive Measures</b>Global Cognitive Functioning Verbal Memory<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>N/A<b>Antipsychotic Dose Recorded</b>N/A<b>CPZ Equivalents Recorded</b>Yes<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>No<br>
DOI: 10.18742/31043515.v1
title: PSYD_3201: UOS

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: Longitudinal </b><b>Study of Individuals with</b><b> Schizophrenia Spectrum and Other Psychotic Disorders (schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, schizotypal personality disorder or psychosis not otherwise specified)</b><b>Contributors and PI’s:</b> Rafael Romero-GarcíaDepartment of Medical Physiology and Biophysics, University of Seville, Spain<br><b>Key Details & Variables</b><pre></pre><b>Age Range</b>15-73<b>Number of Participants</b>224<b>Diagnostic Criteria</b>SCZ, SAD, BPD<b>Number of Clinical Subjects</b>206<b>Number of Clinical Subjects (follow-up)</b>192<b>Number of Control Subjects</b>78<b>Number of Control Subjects (follow-up)</b>189<b>Demographic Information</b>Age, Sex, Ethnicity, Education<b>Clinical Measures</b>SANS, SAPS, BPRS<b>Cognitive Measures</b>Global Cognitive Functioning Verbal Memory<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>N/A<b>Antipsychotic Dose Recorded</b>N/A<b>CPZ Equivalents Recorded</b>Yes<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>No<br>
DOI: 10.15468/dl.uw2ejj
title: Occurrence Download

description: A dataset containing 6032 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Odontocerum albicorne",
 "Year 2015-2025"
 ]
}

 The dataset includes 6032 records from 61 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002831-260120142942310/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.18742/31043344
title: PSYD_3601: AUMC

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: </b><b>C</b><b>ross-Sectional</b><b> Study of Individuals with First Episode Psychosis (FEP)</b><b>Contributors and PI’s:</b> Marieke van der PluijmDepartment of Psychiatry, Amsterdam UMC, University of Amsterdam<br><b>Key Details & Variables</b><pre></pre><b>Age Range</b>17-21<b>Number of Participants</b>78<b>Diagnostic Criteria</b>FEP<b>Number of Clinical Subjects</b>58<b>Number of Clinical Subjects (follow-up)</b>No<b>Number of Control Subjects</b>20<b>Number of Control Subjects (follow-up)</b>No<b>Demographic Information</b>Age, Sex<b>Clinical Measures</b>PANSS<b>Cognitive Measures</b>IQ, MCCB(attention, WM, PS, Verbal Learning, Visual Learning, Reasoning)<b>Clinical Functioning Measures</b>N/A<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>Yes<b>Antipsychotic Dose Recorded</b>Yes<b>CPZ Equivalents Recorded</b>N/A<b>Other Medication Variables Recorded</b>N/A<b>Recreational Drug/ Alcohol Use</b>N/A
DOI: 10.18742/31043344.v1
title: PSYD_3601: AUMC

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: </b><b>C</b><b>ross-Sectional</b><b> Study of Individuals with First Episode Psychosis (FEP)</b><b>Contributors and PI’s:</b> Marieke van der PluijmDepartment of Psychiatry, Amsterdam UMC, University of Amsterdam<br><b>Key Details & Variables</b><pre></pre><b>Age Range</b>17-21<b>Number of Participants</b>78<b>Diagnostic Criteria</b>FEP<b>Number of Clinical Subjects</b>58<b>Number of Clinical Subjects (follow-up)</b>No<b>Number of Control Subjects</b>20<b>Number of Control Subjects (follow-up)</b>No<b>Demographic Information</b>Age, Sex<b>Clinical Measures</b>PANSS<b>Cognitive Measures</b>IQ, MCCB(attention, WM, PS, Verbal Learning, Visual Learning, Reasoning)<b>Clinical Functioning Measures</b>N/A<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>Yes<b>Antipsychotic Dose Recorded</b>Yes<b>CPZ Equivalents Recorded</b>N/A<b>Other Medication Variables Recorded</b>N/A<b>Recreational Drug/ Alcohol Use</b>N/A
DOI: 10.15468/dl.7285f2
title: Occurrence Download

description: A dataset containing 12668 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((-57.11517 -24.14982,-57.12911 -24.20003,-57.11888 -24.27626,-57.08449 -24.32926,-57.03335 -24.3618,-56.93201 -24.39341,-56.79879 -24.40503,-56.67364 -24.38741,-56.64768 -24.38278,-56.58928 -24.36702,-56.53595 -24.33112,-56.5313 -24.27533,-56.54804 -24.16377,-56.63357 -24.07637,-56.67448 -24.06522,-56.78952 -24.06387,-56.87716 -24.06894,-57.06124 -24.1117,-57.11517 -24.14982))",
 "OccurrenceStatus is Present",
 "TaxonKey is Chordata"
 ]
}

 The dataset includes 12668 records from 9 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002832-260120142942310/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.18742/31037053
title: PSYD_0122: KCL

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: </b><b>Longitudinal Study of Individuals with Schizophrenia and Healthy Controls</b><b>Contributors and PI’s:</b> Dr Alice EgertonDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK<br><b>Key Details & Variables</b><pre></pre><b>Age Range</b>18-68<b>Number of Participants</b>32<b>Diagnostic Criteria</b>SCZ / SZA<b>Number of Clinical Subjects</b>22<b>Number of Clinical Subjects (follow-up)</b>14<b>Number of Control Subjects</b>8<b>Number of Control Subjects (follow-up)</b>No<b>Demographic Information</b>Age, Sex<b>Clinical Measures</b>PANSS<b>Cognitive Measures</b>N/A<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>Yes<b>Antipsychotic Dose Recorded</b>Yes<b>CPZ Equivalents Recorded</b>Yes<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>Yes<br>
DOI: 10.18742/31037053.v1
title: PSYD_0122: KCL

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: </b><b>Longitudinal Study of Individuals with Schizophrenia and Healthy Controls</b><b>Contributors and PI’s:</b> Dr Alice EgertonDepartment of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK<br><b>Key Details & Variables</b><pre></pre><b>Age Range</b>18-68<b>Number of Participants</b>32<b>Diagnostic Criteria</b>SCZ / SZA<b>Number of Clinical Subjects</b>22<b>Number of Clinical Subjects (follow-up)</b>14<b>Number of Control Subjects</b>8<b>Number of Control Subjects (follow-up)</b>No<b>Demographic Information</b>Age, Sex<b>Clinical Measures</b>PANSS<b>Cognitive Measures</b>N/A<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>Yes<b>Antipsychotic Dose Recorded</b>Yes<b>CPZ Equivalents Recorded</b>Yes<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>Yes<br>
DOI: 10.18742/31038115
title: PSYD_0123:KCL

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: </b><b>C</b><b>ross-Sectional</b><b> Study of Individuals with Clinical High Risk</b><b>Contributors and PI’s:</b> Dr Paolo Fusar-PoliDept of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, UK<b>Key Details & Variables</b><pre></pre><b>Age Range</b>17-21<b>Number of Participants</b>30<b>Diagnostic Criteria</b>CHR<b>Number of Clinical Subjects</b>30<b>Number of Clinical Subjects (follow-up)</b>No<b>Number of Control Subjects</b>No<b>Number of Control Subjects (follow-up)</b>No<b>Demographic Information</b>Age, Sex, Ethnicity, Education<b>Clinical Measures</b>CAARMS<b>Cognitive Measures</b>N/A<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>Yes<b>Antipsychotic Dose Recorded</b>Yes<b>CPZ Equivalents Recorded</b>N/A<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>No<br>
DOI: 10.18742/31038115.v1
title: PSYD_0123:KCL

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: </b><b>C</b><b>ross-Sectional</b><b> Study of Individuals with Clinical High Risk</b><b>Contributors and PI’s:</b> Dr Paolo Fusar-PoliDept of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, Kings College London, UK<b>Key Details & Variables</b><pre></pre><b>Age Range</b>17-21<b>Number of Participants</b>30<b>Diagnostic Criteria</b>CHR<b>Number of Clinical Subjects</b>30<b>Number of Clinical Subjects (follow-up)</b>No<b>Number of Control Subjects</b>No<b>Number of Control Subjects (follow-up)</b>No<b>Demographic Information</b>Age, Sex, Ethnicity, Education<b>Clinical Measures</b>CAARMS<b>Cognitive Measures</b>N/A<b>Clinical Functioning Measures</b>GAF<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>Yes<b>Antipsychotic Dose Recorded</b>Yes<b>CPZ Equivalents Recorded</b>N/A<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>No<br>
DOI: 10.18742/31043584
title: PSYD_3101: VAL

description: <i>This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.</i><b>Title: Cross-Sectional </b><b>Study of Individuals with</b><b> First Episode Psychosis and </b><b>Schizophrenia</b><b>Contributors and PI’s: </b>Alejandro Roig HerreroPsychiatry Department, School of Medicine, University of Valladolid, Valladolid, Spain<b>Key Details & Variables</b><pre></pre><b>Age Range</b>15-73<b>Number of Participants</b>277<b>Diagnostic Criteria</b>SCZ/ FEP<b>Number of Clinical Subjects</b>158<b>Number of Clinical Subjects (follow-up)</b>No<b>Number of Control Subjects</b>119<b>Number of Control Subjects (follow-up)</b>No<b>Demographic Information</b>Age, Sex, Handness, Education, SES<b>Clinical Measures</b>PANNS, BNSS, IPASE<b>Cognitive Measures</b>IQ, WAIS, BACS, WCST<b>Clinical Functioning Measures</b>N/A<b>Antipsychotic Medication Information Recorded</b>Yes<b>Antipsychotic Medication Name/ Antipsychotic Type</b>N/A<b>Antipsychotic Dose Recorded</b>N/A<b>CPZ Equivalents Recorded</b>Yes<b>Other Medication Variables Recorded</b>No<b>Recreational Drug/ Alcohol Use</b>No<br>